Metraipolis › archive › dc_cd92a10293ee

Sex-specific efficacy and safety outcomes in patients with resectable stage III non-small-cell lung cancer (NSCLC) undergoing neoadjuvant therapies: a pooled… — Europe PMC PMID:41218384

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41218384
DOI: 10.1016/j.esmoop.2025.105870
License (as archived): solo-consultazione
Archived: 2026-11-08T16:59:33.238Z
SHA-256 of the archived text: 76961f5c5758de8ccdeb51dc26386869c206718cfca132a693c3d9f6df2a4195
Stable URL of this page: https://metraipolis.com/documento/dc_cd92a10293ee

How to cite

Sex-specific efficacy and safety outcomes in patients with resectable stage III non-small-cell lung cancer (NSCLC) undergoing neoadjuvant therapies: a pooled… — Europe PMC PMID:41218384 — Europe PMC (en), https://europepmc.org/article/MED/41218384 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_cd92a10293ee (Metraipolis archive dc_cd92a10293ee, sha256 76961f5c5758de8ccdeb51dc26386869c206718cfca132a693c3d9f6df2a4195)

BibTeX

@misc{dccd92a10293ee,
  title = {Sex-specific efficacy and safety outcomes in patients with resectable stage III non-small-cell lung cancer (NSCLC) undergoing neoadjuvant therapies: a pooled… — Europe PMC PMID:41218384},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41218384},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_cd92a10293ee; sha256 76961f5c5758de8ccdeb51dc26386869c206718cfca132a693c3d9f6df2a4195},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41218384. Agents can read the archived copy with the MCP tool read_document.